Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 1.770
-0.085 (-4.58%)
Oct 7, 2026, 4:10 PM AEST
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 347.04 million as of October 7, 2026. That makes Racura Oncology the world's 19,813th most valuable company and 377th in Australia. Its market cap has decreased by 49.32% in one year.
Market Cap
347.04M
Enterprise Value
312.75M
Revenue
2.81M
Global Rank
Country Rank
#377 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 347.04M, an increase of 2,646.20%. That is a compound annual growth rate of 38.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 347.04M | -29.70% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 783.47M |
| Clinuvel Pharmaceuticals | 408.47M |
| Starpharma Holdings | 381.48M |
| Tetratherix | 342.23M |
| BLS Pharmaceuticals | 234.91M |
| Actinogen Medical | 207.78M |
| Orthocell | 206.97M |
| Paradigm Biopharmaceuticals | 146.80M |